Scientific article

Targeting the epithelial cells in fibrosis: a new concept for an old disease

Published inDrug discovery today, vol. 18, no. 11-12, p. 582-591
Publication date2013

Fibrosis, which affects millions of individuals worldwide, is a leading cause of organ failure. For 40 years myofibroblasts have been recognized to be the key cellular players in fibrosis. Currently, several pharmaceutical targets are under investigation that may contribute to the activation of myofibroblasts. Recent preclinical and clinical evidence suggests that other components in the fibrotic microenvironment can trigger myofibroblast activation, providing new targets for pharmaceutical intervention. Epithelial cells may represent the most promising cellular phenotype that could be exploited in the design of new anti-fibrotic medicines through their paracrine action on myofibroblasts. The present review briefly highlights this hypothesis and discusses some interesting related pharmacological targets.

  • Animals
  • Epithelial Cells/metabolism
  • Fibrosis/drug therapy/metabolism/pathology
  • Humans
  • Myofibroblasts/pathology
Citation (ISO format)
MOLL, Solange et al. Targeting the epithelial cells in fibrosis: a new concept for an old disease. In: Drug discovery today, 2013, vol. 18, n° 11-12, p. 582–591. doi: 10.1016/j.drudis.2013.01.006
Main files (1)
Article (Accepted version)
ISSN of the journal1359-6446

Technical informations

Creation12/18/2014 5:58:00 PM
First validation12/18/2014 5:58:00 PM
Update time03/14/2023 10:31:00 PM
Status update03/14/2023 10:31:00 PM
Last indexation01/16/2024 3:23:41 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack